Human genetic susceptibility to intracellular pathogens

Immunological Reviews

Volumn 240, Issue 1, 2011, Pages 105-116

  Vannberg, Fredrik O ^a   Chapman, Stephen J ^a   Hill, Adrian V S ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

AIDS; Bacterial; Infectious diseases; Viral

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 23; TOLL LIKE RECEPTOR 1;

BACTERIAL INFECTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOMICS; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION SENSITIVITY; LEPROSY; MALARIA; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS;

COMMUNICABLE DISEASES; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS; HIV INFECTIONS; HUMANS; LEPROSY; MALARIA; TUBERCULOSIS; VIRUS DISEASES;

EID: 79951877143     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2010.00996.x     Document Type: Review

References (81)

1. Sørensen T, et al. Genetic and environmental influence on premature death in adult adoptees. N Engl J Med 1988;318:727-732.
2. Petersen L, Andersen PK, Sorensen TI. Genetic influences on incidence and case-fatality of infectious disease. PLoS ONE 2010;5:e10603.
3. Comstock GW. Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respir Dis 1978;117:621-624.
4. Stead WW, et al. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N Engl J Med 1990;322:422-427.
5. Casanova JL, Abel L. The human model: a genetic dissection of immunity to infection in natural conditions. Nat Rev Immunol 2004;4:55-66.
6. Doffinger R, et al. Inherited disorders of IL-12- and IFNgamma-mediated immunity: a molecular genetics update. Mol Immunol 2002;38:903-909.
7. Mansouri D, et al. Inherited disorders of the IL-12-IFN-gamma axis in patients with disseminated BCG infection. Eur J Pediatr 2005;164:753-757.
8. van de Vosse E, van Dissel JT, Ottenhoff TH. Genetic deficiencies of innate immune signalling in human infectious disease. Lancet Infect Dis 2009;9:688-698.
9. Berrington WR, Hawn TR. Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter? Immunol Rev 2007;219:167-186.
10. de Vries RR, et al. HLA-linked control of susceptibility to tuberculoid leprosy and association with HLA-DR types. Tissue Antigens 1980;16:294-304.
11. Serjeantson SW. HLA and susceptibility to leprosy. Immunol Rev 1983;70:89-112.
12. Samson M, et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-725.
13. The International HapMap Project Constortium. A haplotype map of the human genome. Nature 2005;437:1299-1320.
14. Barrett JC, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
15. Jallow M, et al. Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet 2009;41:657-665.
16. WTCCC. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 2007;447:661-678.
17. McCarthy MI, et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008;9:356-369.
18. Thye T, et al. Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2. Nat Genet 2010;42:739-741.
19. Wong SH, et al. Leprosy and the adaptation of human toll-like receptor 1. PLoS Pathog 2010;6:e1000979.
20. Wong SH, Hill AV, Vannberg FO. Genomewide association study of leprosy. N Engl J Med 2010;362:1446-1447. author reply 1447-1448.
21. Zhang FR, et al. Genomewide association study of leprosy. N Engl J Med 2009;361:2609-2618.
22. Davila S, et al. Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. Nat Genet 2010;42:772-776.
23. Kamatani Y, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009;41:591-595.
24. Ge D, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009;461:399-401.
25. Rauch A, et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010;138:1338-1345. 1345 e1-7.
26. Suppiah V, et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 2009;41:1100-1104.
27. Thomas DL, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009;461:798-801.
28. Fellay J, et al. Common genetic variation and the control of HIV-1 in humans. PLoS Genet 2009;5:e1000791.
29. Fellay J, et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007;317:944-947.
30. Pelak K, et al. Host determinants of HIV-1 control in African Americans. J Infect Dis 2010;201:1141-1149.
31. Shrestha S, et al. Host genetics and HIV-1 viral load set-point in African-Americans. AIDS 2009;23:673-677.
32. Thomas R, et al. HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet 2009;41:1290-1294.
33. Lonnroth K, et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 2010;375:1814-1829.
34. van der Werf TS, et al. Mycobacterium ulcerans infection. Lancet 1999;354:1013-1018.
35. Pannikar V. Enhanced global strategy for further reducing the disease burden due to leprosy: 2011-2015. Lepr Rev 2009;80:353-354.
36. de Bakker PI, Telenti A. Infectious diseases not immune to genome-wide association. Nat Genet 2010;42:731-732.
37. Pomerantz MM, et al. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet 2009;41:882-884.
38. Shureiqi I, et al. GATA-6 transcriptional regulation of 15-lipoxygenase-1 during NSAID-induced apoptosis in colorectal cancer cells. Cancer Res 2002;62:1178-1183.
39. Liu C, et al. 15-Lipoxygenase-1 induces expression and release of chemokines in cultured human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2009;297:L196-L203.
40. Herb F, et al. ALOX5 variants associated with susceptibility to human pulmonary tuberculosis. Hum Mol Genet 2008;17:1052-1060.
41. Bafica A, et al. Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production. J Clin Invest 2005;115:1601-1606.
42. Divangahi M, et al. Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis. Nat Immunol 2010;11:751-758.
43. Johnson CM, et al. Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J Immunol 2007;178:7520-7524.
44. Misch EA, et al. Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction. PLoS Negl Trop Dis 2008;2:e231.
45. Lemaitre B, et al. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996;86:973-983.
46. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394-397.
47. Fitzgerald KA, et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 2001;413:78-83.
48. Horng T, et al. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 2002;420:329-333.
49. Jin MS, et al. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 2007;130:1071-1082.
50. Khor CC, et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet 2007;39:523-528.
51. Ferwerda B, et al. Functional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by providing protection against septic shock. Proc Natl Acad Sci USA 2009;106:10272-10277.
52. Hawn TR, et al. A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur J Immunol 2007;37:2280-2289.
53. Schuring RP, et al. Polymorphism N248S in the human Toll-like receptor 1 gene is related to leprosy and leprosy reactions. J Infect Dis 2009;199:1816-1819.
54. Cirl C, et al. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat Med 2008;14:399-406.
55. Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med 2000;343:338-344.
56. Pickrell JK, et al. Signals of recent positive selection in a worldwide sample of human populations. Genome Res 2009;19:826-837.
57. Todd JA, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007;39:857-864.
58. Barreiro LB, et al. Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense. PLoS Genet 2009;5:e1000562.
59. Grossman SR, et al. A composite of multiple signals distinguishes causal variants in regions of positive selection. Science 2010;327:883-886.
60. Sabeti PC, et al. Positive natural selection in the human lineage. Science 2006;312:1614-1620.
61. Barreiro LB, et al. Natural selection has driven population differentiation in modern humans. Nat Genet 2008;40:340-345.
62. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004;4:499-511.
63. Saporta L, Yuksel A. Androgenic status in patients with lepromatous leprosy. Br J Urol 1994;74:221-224.
64. Smith DG, Guinto RS. Leprosy and fertility. Hum Biol 1978;50:451-460.
65. Guinto RS, Doull JA, De Guia L. Mortality of persons with leprosy prior to sulfone therapy, Cordova and Talisay, Cebu, Philippines. Int J Lepr 1954;22:273-284.
66. Noordeen SK. Mortality in leprosy. Indian J Med Res 1972;60:439-445.
67. Boldsen JL. Leprosy and mortality in the Medieval Danish village of Tirup. Am J Phys Anthropol 2005;126:159-168.
68. Goldstein DB. Common genetic variation and human traits. N Engl J Med 2009;360:1696-1698.
69. Creagh EM, O'Neill LA. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol 2006;27:352-357.
70. Barrett JC, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008;40:955-962.
71. Baksh FK, et al. Absence of Mycobacterium avium subsp. paratuberculosis in the microdissected granulomas of Crohn's disease. Mod Pathol 2004;17:1289-1294.
72. Spinosa MR, et al. The Neisseria meningitidis capsule is important for intracellular survival in human cells. Infect Immun 2007;75:3594-3603.
73. Leslie A, et al. Additive contribution of HLA class I alleles in the immune control of HIV-1 infection. J Virol 2010;84:9879-9888.
74. Beloqui A, et al. Novel polyphenol oxidase mined from a metagenome expression library of bovine rumen: biochemical properties, structural analysis, and phylogenetic relationships. J Biol Chem 2006;281:22933-22942.
75. Lemonnier M, Landraud L, Lemichez E. Rho GTPase-activating bacterial toxins: from bacterial virulence regulation to eukaryotic cell biology. FEMS Microbiol Rev 2007;31:515-534.
76. Schurr E, Gros P. A common genetic fingerprint in leprosy and Crohn's disease? N Engl J Med 2009;361:2666-2668.
77. Johnson AD, et al. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 2008;24:2938-2939.
78. Alegre-Abarrategui J, et al. LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. Hum Mol Genet 2009;18:4022-4034.
79. Calvano SE, et al. A network-based analysis of systemic inflammation in humans. Nature 2005;437:1032-1037.
80. Grumann D, et al. Immune cell activation by enterotoxin gene cluster (egc)-encoded and non-egc superantigens from Staphylococcus aureus. J Immunol 2008;181:5054-5061.
81. Fairfax BP, et al. An integrated expression phenotype mapping approach defines common variants in LEP, ALOX15 and CAPNS1 associated with induction of IL-6. Hum Mol Genet 2010;19:720-730.